|
|
|
|
Newsletter September 2019
|
|
CVBF future perspectives. An interview to the CEO, Donato Bonifazi
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) has been included in the Financial Times (FT) 1000 report, a list of the companies in 31 European countries that have achieved the highest percentage growth in revenues between 2013 and 2016. We have asked Donato Bonifazi, CEO at CVBF, about the future perspectives and projects for CVBF. |
|
“Quaderni della SIF” journal: a focus on the off-label use in paediatrics
We are pleased to inform you that the n.46 of “Quaderni della SIF”, the journal edited by the Italian Pharmacology Society, has been published and includes the article “The off-label use in paediatrics”. Viviana Giannuzzi (Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus) and Kejla Musaraj (Consorzio per Valutazioni Biologiche e Farmacologiche) are the authors of the article. |
|
First EJP RD General Assembly
On September 17-18, 2019, the first General Assembly of EJP RD will take place in Gdansk, Poland. The General Assembly will be twinned to the workshop “Rare disease perspectives in Central – Eastern Europe”. The European Joint Programme on Rare Diseases (EJPRD) is a Co-fund action aimed to create a comprehensive, sustainable system allowing virtuous circle between research, care and medical innovation. |
|
|
SAVE THE DATE
September 2019, 24-26
|
|
|
European Research & Innovation Days
The European research and innovation days will take place in Brussels, Belgium, and will welcome researchers, scientists, innovators and policy makers. The event will be web streamed and will cover fundamental areas of science, engineering, medicine and wider social and environmental concerns.
|
|
|
|
SAVE THE DATE
October 2019, 2-4
|
|
|
“Shaping the Future of Paediatrics” Conference
Bambino Gesù Children’s Hospital in partnership with the International Society of Pediatric Innovation (iSPI) will organise the Conference “Shaping the Future of Paediatrics” at Centro Congressi Piazza di Spagna in Rome, Italy. The Conference will feature demo sessions on innovation in paediatrics.
|
|
|
|
CVBF and EPTRI at the Europe Biobank Week 2019
Even this year the Europe Biobank Week (EBW) will take place to provide a platform to discuss current issues and future perspectives in the biobanking field. The EBW 2019 edition will take place in Lübeck, Germany, from October 8 until 11. CVBF will participate to the Conference, by presenting two posters.
|
|
|
|
SAVE THE DATE
October 2019, 21-22
|
|
|
4th EPTRI General Assembly Meeting
The 4th EPTRI General Assembly Meeting will be held in Warsaw hosted by the Ministry of Health and organised in collaboration with the Polish partner, the Children Memorial Institute. EPTRI is aimed to design a new paediatric Research Infrastructure, intended to accelerate paediatric drug development including most relevant technological innovations in research for children’s health.
|
|
|
|
SAVE THE DATE
October 2019, 24
|
|
|
EUCROF Training Day on “Essentials of Paediatric Clinical Research”
EUCROF Paediatric Working Group will organise a F2F training that will take place at the Centro Nacional de Invesigaciones Oncológicas in Madrid, Spain. Donato Bonifazi, CEO of CVBF, and member of the EUCROF Paediatric Working Group, will take part in the workshop as speaker, along with several experts who will illustrate what it is needed to know when preparing, conducting and monitoring paediatric clinical trials.
|
|
|
|
39th National Congress of SIF. The achievements of DIVA project will be presented
In the framework of the DIVA (Innovative devices for the prevention of recurrent vaginites) project, the abstract “Innovative approach to recurrent vaginitis” has been accepted for poster presentation at the 39th National Congress of SIF (Società Italiana di Farmacologia) that will take place in Florence, Italy. CVBF is partner in DIVA, a project aimed to develop a specific treatment for vaginitis relapsing with the aim of reducing the antibiotic-therapy.
|
|
|
|
|
|
|
|
|
|
